Research Projects & Grants

For Profit Organization

• A phase 3 prospective, randomized, multi-center, open-label, controlled trial to assess the efficacy and safety of cellular immunotherapy with MDR-101 for induction of immune tolerance in recipients of HLA-matched, living donor kidney transplants, Role: Investigator, Medeor Therapeutics, Inc., (05/2023 - 04/2024) Status: Completed
• Post-marketing requirement study to evaluate the safety of Octaplas™ versus plasma in patients undergoing orthotopic liver transplantation with special emphasis on hyperfibrinolysis, Role: Investigator, Octapharma, (06/2018 - 06/2019) Status: Completed

Internal

• Low-Titer Type O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients, Role: Investigator, LLU Dept. of Surgery, (05/2021) Status: Approved
• Convalescent Plasma to Treat Coronavirus - Associated Severe Pulmonary Complications: A Correlation Study of Serologic Anti-SARS-CoV-2 antibody to Treatment Efficacy and Outcome, Role: Investigator, LLU Basic Science, (06/2020) Status: Approved
• Assessment of pediatric resident knowledge in transfusion medicine, Role: PI, LLU Dept. of Pathology & Human Anatomy, (10/2018) Status: Completed
• Prospective analysis of Type A plasma as an alternative to AB plasma in massive transfusion, Role: Investigator, LLU Dept. of Surgery, (07/2017 - 07/2018) Status: Completed
• Prospective investigation of the relationship between plasma dilution and bypass associated dilutional coagulopathy, Role: Investigator, LLU Dept. of Anesthesiology, (07/2013 - 07/2014) Status: Completed
• Using lean six sigma to decrease delivery time of blood products to the operating room, Role: Investigator, LLU Dept. of Anesthesiology, (10/2017 - 05/2021) Status: Completed